SCSandra Crnko

Sandra Crnko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Crnko has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immune cell engager therapy for brain cancer

    by Daan A Sluijter, Rianne van Garderen, Ilse van Haveren, Jan Meeldijk, Sandra Crnko, Thijs Koorman, Toine Ten Broeke, Michael Y Schakelaar, Niels Bovenschen

    Improving outcomes for patients with brain tumors remains a formidable challenge. Patient survival is often considered very poor even though standard first-line treatments include surgery, radiotherapy, and chemotherapy. These therapies often have detrimental side effects on brain functions and do not suffice when tumors advance and metastasize, prompting the need for new treatment modalities. Recent innovations in antibody-based immunotherapies may complement brain cancer treatment. Biotechnical engineering platforms yield new antibody-inspired biomolecules for optimal engagement of specific and tumor-associated antigens, which also recruit and elicit immune effector cell functions. Here, we review current advances on multi-specific immune cell engagers for brain tumor treatment and provide novel insights into overcoming existing challenges.

  • Undergraduate education as catalyst for public–private partnership in biotechnology

    by Toine Ten Broeke, Thijs Koorman, Sandra Crnko, Erik Voets, Pauline de Goeje, Michael Y. Schakelaar, Heggert G. Rebel, Emma W. Pijnappel, Jorine G. F. Sanders, Jan Meeldijk, et al.


  • Open Access

    Integration of circadian rhythms and immunotherapy for enhanced precision in brain cancer treatment

    by Matthias Quist, Maas van Os, Linda W. van Laake, Niels Bovenschen, Sandra Crnko


  • Open Access

    Uniting education, research, healthcare, and society to advance women’s heart health

    by Michael Y. Schakelaar, Annemieke Maas, Anne-Mar L.N. van Ommen, Anna E. Spiering, Roos de Jonge, Patrick Wijchers, Gerda van Rossum, Balthasar A. Heesters, Olivier G. de Jong, Jelle Zandveld, et al.

    Complex health challenges require professionals to operate across disciplines and to better connect with society. Here, we showcase a community-engaged and challenge-based educational model in which undergraduate students conduct transdisciplinary research on authentic complex biomedical problems. This concept reinforces translational medicine, human capital, and exemplifies synergy between education, research, healthcare, and society.


  • Open Access

    The circadian clock remains intact, but with dampened hormonal output in heart failure

    by Sandra Crnko, Markella I. Printezi, Peter-Paul M. Zwetsloot, Laurynas Leiteris, Andrew I. Lumley, Lu Zhang, Isabelle Ernens, Tijn P.J. Jansen, Lilian Homsma, Dries Feyen, et al.


  • Open Access

    Circadian Dependence of the Acute Immune Response to Myocardial Infarction

    by Aoife B. Kilgallen, Frederieke van Den Akker, Dries A. M. Feyen, Sandra Crnko, Christian J. B. Snijders Blok, Hendrik Gremmels, Bastiaan C. du Pré, Robin Reijers, Pieter A. Doevendans, Saskia C. A. de Jager, et al.

    Circadian rhythms influence the recruitment of immune cells and the onset of inflammation, which is pivotal in the response to ischemic cardiac injury after a myocardial infarction (MI). The hyperacute immune response that occurs within the first few hours after a MI has not yet been elucidated. Therefore, we characterized the immune response and myocardial damage 3 hours after a MI occurs over a full twenty-four-hour period to investigate the role of the circadian rhythms in this response. MI was induced at Zeitgeber Time (ZT) 2, 8, 14, and 20 by permanent ligation of the left anterior descending coronary artery. Three hours after surgery, animals were terminated and blood and hearts collected to assess the immunological status and cardiac damage. Blood leukocyte numbers varied throughout the day, peaking during the rest-phase (ZT2 and 8). Extravasation of leukocytes was more pronounced during the active-phase (ZT14 and 20) and was associated with greater chemokine release to the blood and expression of adhesion molecules in the heart. Damage to the heart, measured by Troponin-I plasma levels, was elevated during this time frame. Clock gene oscillations remained intact in both MI-induced and sham-operated mice hearts, which could explain the circadian influence of the hyperacute inflammatory response after a MI. These findings are in line with the clinical observation that patients who experience a MI early in the morning (i.e., early active phase) have worse clinical outcomes. This study provides further insight on the immune response occurring shortly after an MI, which may contribute to the development of novel and optimization of current therapeutic approaches.


  • Open Access

    Noncytotoxic functions of killer cell granzymes in viral infections

    by Lisanne C. de Jong, Sandra Crnko, Toine Ten Broeke, Niels Bovenschen

    Cytotoxic lymphocytes produce granules armed with a set of 5 serine proteases (granzymes (Gzms)), which, together with the pore-forming protein (perforin), serve as a major defense against viral infections in humans. This granule-exocytosis pathway subsumes a well-established mechanism in which target cell death is induced upon perforin-mediated entry of Gzms and subsequent activation of various (apoptosis) pathways. In the past decade, however, a growing body of evidence demonstrated that Gzms also inhibit viral replication and potential reactivation in cell death–independent manners. For example, Gzms can induce proteolysis of viral or host cell proteins necessary for the viral entry, release, or intracellular trafficking, as well as augment pro-inflammatory antiviral cytokine response. In this review, we summarize current evidence for the noncytotoxic mechanisms and roles by which killer cells can use Gzms to combat viral infections, and we discuss the potential thereof for the development of novel therapies.


  • Open Access

    Prognostic Biomarker Soluble ST2 Exhibits Diurnal Variation in Chronic Heart Failure Patients

    by Sandra Crnko, Markella I. Printezi, Tijn P.J. Jansen, Laurynas Leiteris, Manon G. van der Meer, Hilde Schutte, Martijn van Faassen, Bastiaan C. du Pré, Nicolaas de Jonge, Folkert W. Asselbergs, et al.

    Aim Soluble suppression of tumorigenicity‐2 (sST2) is a strong prognostic biomarker in heart failure. The emerging understanding of circadian biology in cardiovascular disease may lead to novel applications in prognosis and diagnosis and may provide insight into mechanistic aspects of the disease–biomarker interaction. So far, it is unknown whether sST2 exhibits a diurnal rhythm. Repeated measurements of sST2 may aid in clinical decision making. The goal of this study was to investigate whether sST2 exhibits diurnal variation in patients with heart failure with reduced ejection fraction (HFrEF) and in control subjects, thereby enhancing its diagnostic and prognostic values. Methods and results The study comprised 32 subjects: 16 HFrEF patients and 16 controls. Blood was collected at seven subsequent time points during a 24 h time period. sST2, N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), melatonin, and cortisol were measured from serum. Peak values of sST2 clustered at daytime (modal value: 5 p.m.) in 87.6% of all subjects (81.3% of patients, P = 0.021; 93.8% of controls, P = 0.001), and minimum concentrations at night‐time (modal value: 5 a.m.) in 84.4% (87.5% of patients, P = 0.004 81.3% of controls, P = 0.021). A cosinor analysis of mean normalized sST2 values revealed significant cosine shaped 24 h oscillations of patients (P = 0.026) and controls (P = 0.037). NT‐proBNP in contrast did not show a diurnal rhythm, while melatonin and cortisol patterns were intact in all subjects. Conclusions sST2 exhibits a diurnal rhythm with lower values in the morning than in the late afternoon. This new insight could lead to refinement of its diagnostic and prognostic values through specified and consistent sampling times with repeated measurements. For example, by measuring sST2 during the afternoon, when levels are at their highest, false negatives on prognosis prediction could be avoided.


  • Top Cited Papers

    Circadian rhythms and the molecular clock in cardiovascular biology and disease

    by Sandra Crnko, Bastiaan C. Du Pré, Joost P. G. Sluijter, Linda W. Van Laake

    The Earth turns on its axis every 24 h; almost all life on the planet has a mechanism — circadian rhythmicity — to anticipate the daily changes caused by this rotation. The molecular clocks that control circadian rhythms are being revealed as important regulators of physiology and disease. In humans, circadian rhythms have been studied extensively in the cardiovascular system. Many cardiovascular functions, such as endothelial function, thrombus formation, blood pressure and heart rate, are now known to be regulated by the circadian clock. Additionally, the onset of acute myocardial infarction, stroke, arrhythmias and other adverse cardiovascular events show circadian rhythmicity. In this Review, we summarize the role of the circadian clock in all major cardiovascular cell types and organs. Second, we discuss the role of circadian rhythms in cardiovascular physiology and disease. Finally, we postulate how circadian rhythms can serve as a therapeutic target by exploiting or altering molecular time to improve existing therapies and develop novel ones.